GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (LTS:0R19) » Definitions » COGS-to-Revenue

Becton Dickinson (LTS:0R19) COGS-to-Revenue : 0.54 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Becton Dickinson COGS-to-Revenue?

Becton Dickinson's Cost of Goods Sold for the three months ended in Mar. 2024 was $2,741 Mil. Its Revenue for the three months ended in Mar. 2024 was $5,045 Mil.

Becton Dickinson's COGS to Revenue for the three months ended in Mar. 2024 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Becton Dickinson's Gross Margin % for the three months ended in Mar. 2024 was 45.67%.


Becton Dickinson COGS-to-Revenue Historical Data

The historical data trend for Becton Dickinson's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson COGS-to-Revenue Chart

Becton Dickinson Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.58 0.55 0.55 0.58

Becton Dickinson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.57 0.67 0.57 0.54

Becton Dickinson COGS-to-Revenue Calculation

Becton Dickinson's COGS to Revenue for the fiscal year that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=11202 / 19372
=0.58

Becton Dickinson's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2741 / 5045
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton Dickinson  (LTS:0R19) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Becton Dickinson's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 2741 / 5045
=45.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Becton Dickinson COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson (LTS:0R19) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton Dickinson (LTS:0R19) Headlines

No Headlines